Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oxycodone on gastrointestinal function after laparoscopic cholecystectomy
ChiCTR2500109828Phase 4Not yet recruiting
- Sponsor
- Shenzhen Nanshan People's Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in opioid-induced bowel dysfunction (OIBD) (2 arms), sponsored by Shenzhen Nanshan People's Hospital. Primary endpoint: Gastric emptying rate. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on ChiCTR2500109828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109828.